Skip to main content

Table 3 Physicians’ barriers to treat hyperlipidemia among patients with rheumatoid arthritis with their respective priority votes

From: Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis

Level

Sub-level

Rheumatologist Votes (%)a

PCP Votes (%)a

Physician Level

Total Votes, %

87.0

25.0

Conflict regarding ownership of hyperlipidemia management

37.7

0.0

Lack of training and knowledge of hyperlipidemia guidelines

32.1

18.3

Lack of time

11.1

0.8

Focus only on RA

6.2

Prioritize non-pharmacologic measures (diet and exercise)

4.2

Difficulty implementing lifestyle modifications for patients with pain

1.7

Patient Level

Total Votes, %

5.6

69.2

Side effects of statins

2.5

42.5

Patient already on multiple medications

2.5

8.3

Side effects of RA medications and RA drug interactions

0.6

Comorbidities

6.7

Complexity of RA and its treatment

5.8

Patients’ lack of awareness of CVD risk

1.7

Priority of RA symptomology over preventive measures

4.2

System Level

Total Votes, %

7.4%

5.8

Financial barriers (limited insurance coverage, cost of additional medications, cost of repeating labs)

6.2%

0.0

Limited clinic staff support

1.2%

Lack of care coordination

5.8

  1. RA Rheumatoid arthritis, CVD Cardiovascular disease. 0% = that sub-level emerged during the brainstorming session but did not receive votes. “--” = the sub-level did not emerge in the respective group
  2. aTotal votes are calculated based on the number of participating physicians. Each physician had a total of 6 votes (3 for the most important, 2 votes for the second most important, and 1 for the third most important statement). Hence, 27 rheumatologist participated × 6 votes each = 162 votes; 20 PCPs participated × 6 votes = 120 votes